Open AccessImmunogenicity of 2 vs 3 Doses of the Quadrivalent Human Papillomavirus Vaccine in Girls Aged 9 to 13 Years After 60 Months
Author(s) -
Gina Ogilvie,
Chantal Sauvageau,
Marc Dionne,
Shelly McNeil,
Mel Krajden,
Deborah Money,
Simon Dobson
Publication year - 2017
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2017.1840
Subject(s) - medicine , immunogenicity , human papillomavirus vaccine , human papillomavirus , antibody response , randomized controlled trial , clinical trial , antibody , pediatrics , immunology , gardasil , cervical cancer , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom